Importance of Storing Medicines on Required Temperature in Pharmacies and Role of Community Pharmacies in Rural Areas: Literature Review

Sumera Aziz Ali*, Savera Aziz Ali**, Nadir Suhail***
* Senior Instructor, Department of Community Health Sciences, Aga Khan University of Medical Sciences, Karachi, Pakistan.
** Intern Nurse, School of Nursing and Midwifery, Aga Khan University Hospital, Karachi, Pakistan.
*** Research Associate, Department of Paediatrics and Child Health, Aga Khan University Hospital, Karachi, Pakistan.
Periodicity:May - July'2016
DOI : https://doi.org/10.26634/jnur.6.2.6045

Abstract

Medicines are the crucial tools to control and prevent various diseases. Ineffective medicines can cause wastage of resources. The efficacy of medicines gets affected due to improper storage conditions particularly the improper temperature. The objective of this review was to synthesize the findings regarding the storage of medicines on required temperature in Pharmacies and the role of community pharmacies, particularly in rural areas. An extensive literature review was carried by retrieving articles from various databases like Pub med, Google scholar and Science Direct and by using terms like 'temperature', 'pharmacy ', 'medicines' and 'storage'. Types of studies were descriptive studies, systematic reviews, and various WHO reports. Normal storage conditions mean storage in dry, well-ventilated place at temperatures of 15–25 °C or, depending on climatic conditions and properties of the drug; it might go up to 30oC. Furthermore, uninterrupted cold chain maintenance is required from the manufacturer till the dispensing of the medicines. Temperature monitoring devices must be used, in order to ensure the appropriate temperature of the medicines during transportation from one to another place. Medicinal products require appropriate storage conditions in order to ensure the quality and efficacy of medicines. Improper storage can increase the unnecessary burden on the economy of general population due to their poor efficacy. Strong monitoring of storage conditions is required to ensure storage practices in community pharmacies. Furthermore, ongoing training should be arranged for pharmacy owners to teach them about standard storage practices, particularly in rural areas.

Keywords

Temperature, Community Pharmacy, Medicines.

How to Cite this Article?

Ali, S.A., Ali, S.A., and Suhail, N. (2016). Importance of Storing Medicines on Required Temperature in Pharmacies and Role of Community Pharmacies in Rural Areas: Literature Review. i-manager’s Journal on Nursing, 6(2), 32-42. https://doi.org/10.26634/jnur.6.2.6045

References

[1]. Butt ZA, Gilani AH, Nanan D, Sheikh AL, and White F. (2005). “Quality of pharmacies in Pakistan: A crosssectional survey”. International Journal for Quality in Health Care, Vol.17, No.4, pp.307-13.
[2]. Hafeez A, Kiani AG, Din Su, Muhammad W, Butt K, Shah Z, et al. (2004). “Prescription and Dispensing Practices in Public Sector Health Facilities in Pakistan-Survey Report”. Journal of Pakistan Medical Association, Vol.54, No.4, pp.187-91.
[3]. Bott RF, Oliveira WP. (2007). “Storage conditions for stability testing of pharmaceuticals in hot and humid regions”. Drug Development and Industrial Pharmacy, Vol.33, No.4, pp.393-401.
[4]. Syhakhang L, Freudenthal S, Tomson G and Wahlstrom R. (2004). “Knowledge and perceptions of drug quality among drug sellers and consumers in Lao PDR”. Health Policy and Planning, Vol.19, No.6, pp.391-401.
[5]. Okeke CC, Bailey L, Medwick T, and Grady LT. (2000). “Revised USP standards for product dating, packaging, and temperature monitoring”. American Journal of Health- System Pharmacy, Vol.57, No.15, pp.1441-5.
[6]. Alam MT, and Aftab K. (1996). “Quality Assurance and Good Manufacturing Practices”. Pakistan Journal of Pharmaceutical Sciences, Vol.9, No.2, pp.69-31.
[7]. Du B, Daniels VR, Vaksman Z, Boyd JL, Crady C, Putcha L. (2011). “Evaluation of physical and chemical changes in pharmaceuticals flown on space missions”. The AAPS Journal, Vol.13, No.2, pp.299-308.
[8]. Abegunde D. (2013). Essential Medicines for Non- Communicable Diseases (NCDs) and Pharmaceutical Policies by WHO. Essential Medicines and Health Products Information Portal.
[9]. Arshad A, Riasat M, and Mahmood MKT, (2011). “Drug Storage Conditions in Different Hospitals in Lahore”. Journal of Pharmaceutical Sciences and Technology, Vol.3, No.1, pp.543-47.
[10]. WHO (1996). Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-Fourth Report. Geneva, World Health Organization. WHO Technical Report Series, 863.
[11]. Good Storage Practice, (1980). “Joint report of the Committee for Official Laboratories and Medicinal Control Services and the Industrial Pharmacists Section of the International Pharmaceutical Federation (FIP)”. Pharm Ind. Vol.42, pp.1082-5.
[12]. Quality Assurance of Pharmaceuticals, (1999). “A compendium of guidelines and related materials”. Good Manufacturing Practices and Inspection, Geneva, World Health Organization. Vol.2.
[13]. Good Trade and Distribution Practice (GTDP) of pharmaceutical starting materials. Geneva, World Health Organization, (unpublished document QAS/01.014; available on request from Essential Drugs and Medicines Policy, World Health Organization, 1211 Geneva 27, Switzerland). 2002.
[14]. WHO, (n.d.). Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-fourth report. Geneva, World Health Organization. WHO Technical Report Series. 1996;863.
[15]. “Good manufacturing practices for pharmaceutical products”. In: Quality Assurance of Pharmaceuticals: A Compendium of Guidelines and Related Materials, Volume 2. Good manufacturing practices and inspection. Geneva, World Health Organization, 1999; WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-Fifth report. Geneva, World Health Organization. WHO Technical Report Series. 1999(885).
[16]. Adhikari R, Soonthorndhada K, and Prasartkul P. (2009). “Correlates of unintended pregnancy among currently pregnant married women in Nepal”. BMC International Health and Human Rights. Vol.9, No.1, pp.17.
[17]. The International Pharmacopoeia, 3rd ed. Vol. 1: General methods of analysis; Vol. 2: Quality specifications; Vol. 3: Quality specifications; Vol. 4: Tests, methods, and general requirements. Quality specifications for pharmaceutical substances, excipients, and dosage forms; Vol.5: Test and general requirements for dosage forms. Quality specifications for pharmaceutical substances and tablets (in press). Geneva, World Health Organization, 1979 - 2002.
[18]. Islam MM, and Rashid M. (2005). “Determinants of unintended pregnancy among ever-married women in Bangladesh”. Journal of Family Welfare, Vol.50, No.2, pp.40.
[19]. N.C. Obitte AC, D.C. Odimegwu and V.C. Nwoke. (2009). “Survey of drug storage practice in homes, hospitals and patent medicine stores in Nsukka, Nigeria”. Scientific Research and Essay, Vol.4, No.11, pp.1354-9.
[20]. Dodo ANO, S H. (2002). “Medicine safety in West Africa”. West African Journal of Pharmacy, Vol.16, No.1, pp.1-4.
[21]. The Uppsala Monitoring Centre, (2000). WHO collaborating Centre for International Drug Monitoring. Safety Monitoring of Medicinal Products: Guidelines for Setting up and Running a Pharmacovigilance Centre.
[22]. Thome J-M, and Pholsena S. (2009). “Lao People's Democratic Republic: Health financing reform and challenges in expanding the current social protection schemes”. Promoting Sustainable Strategies to Improve Access to Health Care in the Asian and Pacific Region, pp.71-102.
[23]. Bardin C, Astier A, Vulto A, Sewell G, Vigneron J, Trittler R, et al., (2011). “Guidelines for the practical stability studies of anticancer drugs: A European consensus conference”. Annales Pharmaceutiques francaises: Elsevier, Vol.69, No.4, pp.221-231.
[24]. Bell KN, Hogue CJR, Manning C, and Kendal AP. (2001). “Risk factors for improper vaccine storage and handling in private provider offices”. Pediatrics, Vol.107, No.6, pp.100-e.
[25]. Azhar Hussain Mimi. (2011). “Qualification, knowledge and experience of dispensers working at community pharmacies in Pakistan”. Pharm Pract (Granada), Vol.9, No.2, pp.93-100.
[26]. Syhakhang L. (2002). “The quality of private pharmacy services in a province of Lao PDR: Perceptions, practices and regulatory enforcements”. Division of International Health/Department of Public Health Sciences.
[27]. Zaidi S, Nishtar NA and Nourneen, (2013). “Rational Prescription & Use: A Snapshot of the Evidence from Pakistan and Emerging Concerns”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol.5, No.1, pp.131-135.
[28]. Wtto Portal, (2003). Guidelines for the Storage of Essential Medicines and Other Health Commodities.
[29]. Nogueira FHA, Moreira-Campos LM, Santos RLCd, and Pianetti GA, (2011). “Quality of essential drugs in tropical countries: Evaluation of antimalarial drugs in the Brazilian Health System”. Revista da Sociedade Brasileira de Medicina Tropical, Vol.44, No.5, pp.582-6.
[30]. Sabine Kopp, (2006). “Stability testing of pharmaceutical products in a global environment”. Regul Aff J, pp.291-4.
[31]. Crichton B. (2004). “Keep in a cool place: exposure of medicines to high temperatures in general practice during a British heatwave”. JRSM. Vol.97, No.7, pp.328-9.
[32]. Bawazir SA. (2004). “Consumer attitudes towards community pharmacy services in Saudi Arabia”. International Journal of Pharmacy Practice, Vol.12, No.2, pp.83-9.
[33]. Qadwai W et al., (2006). “Private drug sellers education in improving prescribing practices”. J Col Physic Surg Pak, Vol.16, pp.743-6.
[34]. Patel KT, and Chotai NP. (n.d.). “Pharma science monitor”. Int J Pharm Sci, pp.1980-93.
[35]. Pau AK, Moodley NK, Holland DT, Fomundam H, Matchaba GU, and Capparelli EV. (2005). “Instability of lopinavir/ritonavir capsules at ambient temperatures in sub- Saharan Africa: Relevance to WHO antiretroviral guidelines”. Aids, Vol.19, No.11, pp.1233.
[36]. Hogerzeil HV, Battersby A, Srdanovic V, and Stjernstrom NE. (2005). “Stability of essential drugs during shipment to the tropics”. BMJ: British Medical Journal, Vol.304, No.6821, pp.210.
[37]. Haworth EA, Booy R, Stirzaker L, Wilkes S, and Battersby A. (1992). “Is the cold chain for vaccines maintained in general practice?”, BMJ: British Medical Journal. Vol.307, No.6898, pp.242.
[38]. Colero MD. (2012). Storage of Medicines and Medical Products.
[39]. Butt ZA GA, Nanan D, Sheikh AL, and White F. (2005). “Quality of pharmacies in Pakistan: A cross-sectional survey”. International Journal for Quality in Health Care, Vol.17, No.4, pp.307-13.
[40]. Mahbub-ul-Haq. (1998). Human Development in South Asia. Oxford University Press, Karachi.
[41]. S F-P. (2002). Human Development Report, Deepening Democracy in a Fragmented World. New York: Oxford University Press.
[42]. Hafeez-ur-Rahman, (1999). Manual of Drug Laws nd 1999. Pioneer Book House, 2 ed. Karachi.
[43]. Organization. WH. (2000). Role of Dispensers in Promoting Rational Drug Use.
[44]. Corelli RL, Zillich AJ, de Moor C, Giuliano MR, Arnold J, Fenlon CM, et al. (2013). “Recruitment of community pharmacies in a randomized trial to generate patient referrals to the tobacco quitline”. Research in Social and Administrative Pharmacy. Vol.9, No.4, pp.396-404.
[45]. Rafie S, Kim GY, Lau LM, Tang C, Brown C, and Maderas NM. (2013). “Assessment of Family Planning Services at Community Pharmacies in San Diego, California”. Pharmacy, Vol.1, No.2, pp.153-9.
[46]. Farris KB F-LF, Benrimoj SIC. (2005). “Pharmaceutical care in community pharmacies: Practice and research from around the world”. Annals of Pharmacotherapy, Vol.39, No.9, pp.1539-41.
[47]. Blenkinsopp A, Anderson C and Armstrong M. (2003). “Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease”. Journal of Public Health, Vol.25, No.2, pp.144-53.
[48]. The NHS Information Centre, (2012). General Pharmaceutical Services in England 2001-02 to 2010-11. London: The Health and social Care Information Centre. Retrieved from: http://www.ic.nhs.uk/statistics-and-datacollections/ primary-care/pharmacies.
[49]. Adepu R NB. (2006). “General practitioners' perceptions about the extended roles of the community pharmacists in the state of Karnataka: A study”. Ind J Pharma Sci., Vol.68, pp.36-40.
[50]. Viberg N. (2009). “Selling Drugs or Providing Health Care?: The role of private pharmacies and drugstores, examples from Zimbabwe and Tanzania”. Division of Global Health/Department of Public Health Sciences.
[51]. Hussain A, and Ibrahim MIM. (2011). “Perceptions of Dispensers regarding dispensing practices in Pakistan: A Qualitative Study”. Tropical Journal of Pharmaceutical Research, Vol.10, No.2.
[52]. Taylor J. (2001). “Recommendations on the control and monitoring of storage and transportation temperatures of medicinal products”. The Pharmaceutical Journal, Vol.267, No.28, pp.128-31.
[53]. Jacobs S, Hassell K, Ashcroft D, Johnson S, and Connor E. (2014). “Workplace stress in community pharmacies in England: Associations with individual, organizational and job characteristics”. Journal of Health Services Research & Policy. Vol.19, No.1, pp.27-33.
[54]. Astin JA. (1998). “Why patients use alternative medicine: results of a national study”. JAMA, Vol.279, No.19, pp.1548-53.

Purchase Instant Access

Single Article

North Americas,UK,
Middle East,Europe
India Rest of world
USD EUR INR USD-ROW
Pdf 35 35 200 20
Online 35 35 200 15
Pdf & Online 35 35 400 25

If you have access to this article please login to view the article or kindly login to purchase the article
Options for accessing this content:
  • If you would like institutional access to this content, please recommend the title to your librarian.
    Library Recommendation Form
  • If you already have i-manager's user account: Login above and proceed to purchase the article.
  • New Users: Please register, then proceed to purchase the article.